Casdin Capital as of Sept. 30, 2022
Portfolio Holdings for Casdin Capital
Casdin Capital holds 36 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eqrx | 12.9 | $196M | 40M | 4.95 | |
| Biolife Solutions Com New (BLFS) | 11.3 | $172M | 7.6M | 22.75 | |
| Sarepta Therapeutics (SRPT) | 8.9 | $135M | 1.2M | 110.54 | |
| Alnylam Pharmaceuticals (ALNY) | 8.5 | $130M | 648k | 200.16 | |
| Blueprint Medicines (BPMC) | 7.4 | $112M | 1.7M | 65.89 | |
| Verve Therapeutics (VERV) | 7.2 | $109M | 3.2M | 34.35 | |
| Relay Therapeutics (RLAY) | 6.9 | $105M | 4.7M | 22.37 | |
| Illumina (ILMN) | 4.8 | $74M | 385k | 190.79 | |
| Maxcyte (MXCT) | 4.6 | $70M | 11M | 6.50 | |
| Revolution Medicines (RVMD) | 3.3 | $50M | 2.5M | 19.72 | |
| Fate Therapeutics (FATE) | 3.0 | $46M | 2.1M | 22.41 | |
| Somalogic Class A Com | 2.4 | $37M | 13M | 2.90 | |
| Century Therapeutics (IPSC) | 2.1 | $32M | 3.2M | 9.89 | |
| EXACT Sciences Corporation (EXAS) | 2.1 | $31M | 967k | 32.49 | |
| Denali Therapeutics (DNLI) | 2.0 | $31M | 995k | 30.69 | |
| Mirati Therapeutics Call Option | 1.6 | $24M | 350k | 69.84 | |
| Absci Corp (ABSI) | 1.6 | $24M | 7.7M | 3.13 | |
| Beam Therapeutics (BEAM) | 1.2 | $18M | 370k | 47.64 | |
| Intellia Therapeutics (NTLA) | 1.1 | $17M | 295k | 55.96 | |
| Abcellera Biologics (ABCL) | 1.1 | $16M | 1.7M | 9.89 | |
| Pliant Therapeutics (PLRX) | 1.0 | $16M | 750k | 20.89 | |
| Sema4 Holdings Corp Com Cl A | 0.9 | $14M | 16M | 0.88 | |
| Twist Bioscience Corp (TWST) | 0.8 | $13M | 365k | 35.24 | |
| Tenaya Therapeutics (TNYA) | 0.7 | $10M | 3.6M | 2.90 | |
| 2seventy Bio Common Stock (TSVT) | 0.6 | $8.9M | 615k | 14.55 | |
| Arvinas Ord (ARVN) | 0.6 | $8.9M | 200k | 44.49 | |
| Celldex Therapeutics Com New (CLDX) | 0.3 | $4.6M | 165k | 28.11 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $4.2M | 511k | 8.17 | |
| Moderna (MRNA) | 0.3 | $3.8M | 33k | 118.25 | |
| Singular Genomics Systems In | 0.2 | $3.4M | 1.3M | 2.50 | |
| Invitae (NVTAQ) | 0.2 | $2.8M | 1.1M | 2.46 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.1 | $2.3M | 80k | 28.26 | |
| Exscientia Ads (EXAI) | 0.1 | $1.8M | 214k | 8.21 | |
| Magenta Therapeutics | 0.0 | $451k | 320k | 1.41 | |
| Kronos Bio (KRON) | 0.0 | $415k | 124k | 3.35 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $411k | 206k | 1.99 |
